Skip to main content
NGL Fine Chem Ltd. logo

NGL Fine Chem Ltd. — Investor Relations & Filings

Ticker · NGLFINE ISIN · INE887E01022 LEI · 335800X5TUU2OAV19X07 BSE.NS Manufacturing
Open in API
Filings indexed 308 across all filing types
Latest filing 2025-07-22 Regulatory Filings
Country IN India
Listing BSE.NS NGLFINE

About NGL Fine Chem Ltd.

https://www.nglfinechem.com

NGL Fine Chem Ltd. specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates for both veterinary and human healthcare sectors. The company focuses on high-quality chemical synthesis, producing a diverse range of products including anthelmintics, ectoparasiticides, and specialty chemicals. Key products in its portfolio include Nitroxynil, Closantel, Oxyclozanide, and Triclabendazole. Operating with Good Manufacturing Practice (GMP) standards, the firm serves a global clientele, providing customized manufacturing solutions and maintaining a strong emphasis on research and development to enhance process efficiency and product quality. Its technical expertise lies in complex chemical reactions and large-scale production of niche pharmaceutical components.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-22 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice informing the stock exchanges about the upcoming Board Meeting scheduled to approve unaudited financial results for the quarter ended June 30, 2025. It is a short announcement (1507 characters) and does not contain any actual financial data or detailed financial statements. It serves to notify the market and regulators about the meeting date and agenda, specifically the approval of quarterly financial results. According to the MENU VS MEAL RULE, such a notice is not the financial report itself but an announcement related to it. Therefore, this document should be classified as a Regulatory Filing (RNS), which is the fallback category for general regulatory announcements and notices that do not fit other specific categories.
2025-07-22 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018, certifying the dematerialization of securities for the quarter ended June 30, 2025. It includes confirmation from the Registrar and Transfer Agent and details of share certificates dematerialized during the period. The document is a regulatory compliance certificate related to securities dematerialization and does not contain financial statements, management discussion, or other report content. It is not an announcement of a report but a regulatory filing confirming compliance with SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS). The document length is 4015 characters, which is relatively short and consistent with a regulatory certificate rather than a full report.
2025-07-10 English
Reply to Clarification- Financial results
Regulatory Filings
2025-07-10 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-07-03 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-07-03 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.